A new data analysis by KHN and Johns Hopkins researchers shows that even as the CDC issued warnings, surgeons handed out many times the number of opioid pills needed for post-op pain.
The federal government has doled out at least $2.4 billion in state grants since 2017 to address the opioid epidemic, which killed 47,600 people in the U.S. that year alone. But local officials note that drug abuse problems seldom involve only one substance.
In its latest update to the Nursing Home Compare website, the government gave 1,638 homes its lowest star rating for staffing — one star on its five-star scale. Most were downgraded because payroll records reported no registered-nurse hours at all for at least four days.
A Kaiser Health News database shows that $58 million flowed from drugmakers to patient groups running national ads.
A new Kaiser Health News database tracks campaign donations from drugmakers over the past 10 years.
No one tracks sepsis cases closely enough to know how often these severe infections turn fatal. But the toll — both human and financial — is enormous, finds an investigation by KHN and the Chicago Tribune.
Medicare said those homes either lacked a registered nurse for “a high number of days” over three months, provided data the government couldn’t verify or didn’t supply their payroll data at all.
Denmark-based drugmaker Novo Nordisk has invested more in lobbying and doubled political donations since 2015.
Kaiser Health News launches “Pre$cription for Power,” a groundbreaking database to expose Big Pharma’s ties to patient groups.
With the nation’s opioid crisis, urine testing has become a booming business and is especially lucrative for doctors who operate their own labs, a Kaiser Health News investigation finds. And dozens of practitioners have earned ‘the lion’s share’ of their Medicare income exclusively from urine drug screens.